79
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis

, , , , , & show all
Pages 523-534 | Received 03 Mar 2006, Accepted 12 Jul 2006, Published online: 08 Jul 2009

References

  • Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: 19–20
  • Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–25
  • Thom D. H., Grayston J. T., Siscovick D. S., Wang S. P., Weiss N. S., Daling J. R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary disease. JAMA 1992; 268: 68–72
  • Linnanmaki E., Leinonen M., Mattila K., Nieminen M. S., Valtonen V., Saikku P. Chlamydia pneumoniae – specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130–4
  • Hoffmeister A., Rothenbacher D., Wanner P., Bode G., Persson K., Brenner H., et al. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease. J Am Coll Cardiol 2000; 35: 112–18
  • Ridker P. M., Kundsin R. B., Stampfer M. J., Poulin S., Hennekens C. H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 9: 1161–4
  • Haider A. W., Wilson P. W. F., Larson M. G., Evans J. C., Michelson E. L., Wolf P. A., et al. The Association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002; 40: 1408–13
  • Young J. L., Libby P., Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88: 554–67
  • Kohara K., Tabara Y., Yamamoto Y., Igase M., Miki T. Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community‐dwelling subjects: the Shimanami Health Promoting Program (J‐SHIPP) study. Stroke 2002; 33: 1474–9
  • Kaukoranta‐Tolvanen S. S. E., Teppo A. M., Laitinen K., Saikku P., Linnavuori K., Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996; 21: 215–21
  • Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C‐reactive protein, albumin, or leukocyte count with coronary heart disease – meta‐analyses of prospective studies. JAMA 1998; 279: 1477–82
  • Leinonen M., Saikku P. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J 1999; 138: 504–6
  • Laurila A., Bloigu A., Nayha S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910–13
  • Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–9
  • Oberman A., Jones W. B., Riley C. P., Reeves T. J., Sheffield L. T., Turner M. E. Natural history of coronary artery disease. Bull NY Acad Med 1972; 48: 1109–25
  • Gensini G. G., Kelly A. E. Reassessment of contrast agent for coronary angiography. Curr Ther Res Clin Exp 1976; 19: 631–6
  • Kiechl S., Egger G., Mayr M., Wiedermann C. J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001; 103: 1064–70
  • Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., Pauletto P. C‐reactive protein and interleukin‐6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003; 21: 1787–803
  • Thom D. H., Wang S. P., Grayston J. T., Siscovick D. S., Stewart D. K., Kronmal R. A., et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547–51
  • Jaremo A., Richter A. Chlamydia pneumoniae IgG and the severity of coronary atherosclerosis. Eur J Intern Med 2004; 15: 508–10
  • Romano S., Penco M., Fratini S., Di Pietro M., Sessa R., Del Piano M., et al. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Int J Cardiol 2004; 95: 95–9
  • Nishimura M., Hashimoto T., Kobayashi H., Fukuda T., Okino K., Yamamoto N., et al. Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 1944–50
  • Halme S., von Hertzen L., Bloigu A., Kaprio J., Koskenvuo M., Leinonen M., et al. Chlamydia pneumoniae‐specific cell‐mediated and humoral immunity in healthy people. Scand J Immunol 1998; 47: 517–20
  • Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease. Eur J Clin Invest 2005; 35: 431–7
  • Paltiel O., Kark J. D., Leinonen M., Saikku P. High prevalence of antibodies to Chlamydia pneumoniae: determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 1995; 114: 465–73
  • Ferrari M., Poli A., Olivieri M., Tardivo S., Biasin C., Balestreri F., et al. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. European Community Respiratory Health Survey (ECRHS) Verona. Infection 2000; 28: 38–41
  • Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., et al. High‐density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8–15
  • Laurila A., Bloigu A., Nayha S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910–13
  • Turkoglu C., Sonmez E., Aydinli A. Relationship between dyslipidemia, C‐reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases. New Microbiol 2004; 27: 229–34
  • Beisal W. R. Metabolic response to infection. Ann Rev Med 1975; 26: 9–20
  • Koh W. P., Taylor M. B., Hughes K., Chew S. K., Fong C. W., Phoon M. C., et al. Seroprevalence of IgG against Chlamydia pneumoniae in Chinese Malays and Asian Indians in Singapore. Int J Epidemiol 2002; 31: 1001–7
  • Netea M. G., Selzman C. H., Kullberg B. J., Galama J. M., Weinberg A., Stalenhoef A. F., et al. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30: 541–9
  • Haddy N., Sass C., Droesch S., Zaiou M., Siest G., Ponthieux A., et al. IL‐6, TNF‐alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003; 170: 277–83
  • Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 2002; 164: 153–60
  • Mendall M. A., Patel P., Ballam L., Strachan D., Northfield T. C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996; 312: 1061–5
  • Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL‐6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–25
  • Schumacher A., Seljeflot I., Lerkerod A. B., Sommervoll L., Otterstad J. E., Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?. Clin Microbiol Infect 2002; 8: 654–61
  • Hu H., Pierce G. N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747–53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.